Study of the Aliviado DSD Caregiving Mastery Program
Key facts
- Who runs it
- NYU Langone Health
- Where
- New York and Pittsburgh, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 33 people enrolled
- Started
- 20 Dec 2023
- Ended
- 11 Feb 2025
- Type of study
- Interventional
- Treatments tested
- Aliviado DSD Caregiving Mastery Program
- Record updated
- 10 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- To be eligible as a "dementia caregiver" in the co-design workshop, an individual must:
- be at least 18 years old,
- be English-speaking,
- provide at least 8 hours of unpaid care weekly or live with a community-dwelling PLWD,
- self-identify as unfamiliar with DSD,
- have the capacity to consent, and
- have Internet access; To be eligible as a "DSD caregiver" in the co-design workshop, an individual must:
- be at least 18 years old,
- be English-speaking,
- be a current or past dementia caregiver with experience caring for a relative or friend during his/her DSD episode within the past 12 months,
- have the capacity to consent, and
- have Internet access; To be eligible to participate in the feasibility trial, an individual must meet all of the following criteria:
- Being 18 years old or older,
- English-speaking,
- Providing at least 8 hours of unpaid care per week to, or living with, a community dwelling PLWD whose Delirium Risk Assessment Score >=5,
- Having the capacity to give informed consent, and
- Having a smartphone with Internet access
Who cannot take part
- Individuals who are blind or deaf will be excluded
Where in United States
- NYU Langone HealthNew York, United States
- University of PittsburghPittsburgh, United States
About the trial
What the trial wants to find out
Delirium superimposed on dementia (DSD) is an acute and serious condition that is common in persons living with dementia (PLWD). Involvement of family caregivers may aid prevention, early detection, and management of DSD. The purpose of the proposed study is two-fold. First, the investigators will develop a family-centered, mHealth-enhanced DSD caregiving mastery program ("Aliviado DSD Caregiving Mastery Program") through a 5-week co-design workshop with 8 family caregivers (Aim 1). The investigators will adapt/refine the existing clinician-centered DSD contents and an mHealth app from the evidence-based "Aliviado Dementia Care" program for use by family caregivers to support their day-to-day implementation of DSD detection, prevention, and management tasks in the community. Second, the investigators will pilot test the full Aliviado DSD Caregiving Mastery Program with family caregivers of PLWD at high risk for delirium, assessing feasibility, acceptability, app usability, and preliminary program impact (Aim 2).
The group in the trial
- Family Caregivers of PLWD at High Risk for DeliriumTreatment being tested
Participants will complete the Aliviado DSD Caregiving Mastery Program. This involves a caregiver education/training period from Week 0 to Week 2, and an implementation period from Week 3 to Week 6.
Treatment: Aliviado DSD Caregiving Mastery Program
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Development and Piloting of a Family-Centered, mHealth-Enhanced Intervention to Promote Caregiving Mastery in Detection, Prevention, and Management of Delirium Superimposed on Dementia
- Record updated
- 10 February 2026